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Abstract
Background: In recent years it has been demonstrated that structural variations, such as indels
(insertions and deletions), are common throughout the genome, but the implications of structural
variations are still not clearly understood. Long tandem repeats (e.g. microsatellites or simple
repeats) are known to be hypermutable (indel-rich), but are rare in exons and only occasionally
associated with diseases. Here we focus on short (imperfect) tandem repeats (STRs) which fall
below the radar of conventional tandem repeat detection, and investigate whether STRs are targets
for disease-related mutations in human exons. In particular, we test whether they share the
hypermutability of the longer tandem repeats and whether disease-related genes have a higher STR
content than non-disease-related genes.
Results: We show that validated human indels are extremely common in STR regions compared
to non-STR regions. In contrast to longer tandem repeats, our definition of STRs found them to be
present in exons of most known human genes (92%), 99% of all STR sequences in exons are shorter
than 33 base pairs and 62% of all STR sequences are imperfect repeats. We also demonstrate that
STRs are significantly overrepresented in disease-related genes in both human and mouse. These
results are preserved when we limit the analysis to STRs outside known longer tandem repeats.
Conclusion: Based on our findings we conclude that STRs represent hypermutable regions in the
human genome that are linked to human disease. In addition, STRs constitute an obvious target
when screening for rare mutations, because of the relatively low amount of STRs in exons
(1,973,844 bp) and the limited length of STR regions.
Background
A striking feature of the human genome is its plasticity,
which is illustrated by the many occurrences of structural
variations such as indels and copy number variations [1-
6]. Exonic structural variation may have a direct influence
on gene products, and hence of interest for e.g. resequenc-
ing studies. In an earlier paper we studied STRs (originally
called periodic DNA; see Figure 1 and Methods for a defi-
nition) and demonstrated that STRs, in contrast to longer
tandem repeats, are common in exonic regions, and that
SNPs are more frequent in STRs compared with non-STRs
[7]. Long intergenic tandem repeats are well known tar-
gets for structural variation, and in this study we investi-
gate whether exonic STRs share this property, and hence
may serve as a probable target for exonic disease causing
mutations.
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The tandem repeat content of mammalian genomes has
been investigated in several papers, generally confining
the analysis to intergenic regions and/or assuming the
repeat element is repeated many times [8-14]. Reports on
tandem repeat sequences in human exons have found that
almost all repeats have a period (unit size) that follows
the codon size (i.e. a period of 3, 6 or 9 bp) [8,13,15]. In
concordance, most known repeat-related diseases are
caused by expansion of 3-repeat elements (Trinucleotide
Disease) in relatively long tandem repeats [15], but other
types of length variations may likewise contribute to dis-
ease risk. Here we focus on a class of very short tandem
repeats and their contribution to disease risk.
We found a strong excess of validated indels in STR
regions and demonstrated that exonic STRs are likely tar-
gets for disease causing mutations by showing that dis-
ease-related genes have a significantly higher STR content
than non-disease-related genes.
Results
STR content
Initially, we annotated the human and mouse genomes
with STRs (see Figure 1 for an example and Methods for
how STRs are identified). The identified STRs make up
4.02% of the human genome, and the majority of the
identified STR segments (62.1%) are imperfect repeats
regions, i.e. they contain polymorphic base-pairs or base-
pairs that do not match the periodic pattern. It appeared
that 92.23% of all known human genes have STRs in their
exons and 99% of STR regions are shorter than 33 bp. The
short length differentiates exonic STRs from known
exonic tandem repeats because the two groups share little
overlap; 96.42 % of the identified STRs are shorter than 25
Example of a STR Figure 1
Example of a STR. A STR is a segment of DNA with a strong periodic pattern. A segment of DNA is defined as STR if (1) 
the minimum length is 9 bp, (2) a sequence motif (e.g., AT in ATATATATAT) is repeated at least three times, (3) there are 
only few base pairs that do not match the periodic motif (see Methods). The example shows an exonic STR region located in 
the nestin (NES) gene on chromosome 1.
G CTGGAGCAGAGA AGAGGAGC
C
ATCCT
STR (period=2)
CCT CC CA CCC TGTG TCT GGAG CAGAGAGAGAG GAG CA TCCT GGG CTCT GA TCTC TGC
rs6696672
R G G Q T Q L L S L P A D Q A R I E A
CCDS1151 (NES Nestin)
chr1:154,904,174 - 154,916,395
STRs
SNPs
Mammal Conservation
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bp and outside known tandem repeats as defined by the
UCSC Simple Repeats track (see Methods).
Indels and STRs
When looking at known indels, we found that STRs are
related to hypermutability. Insertions as well as deletions
are much more common inside than outside STR regions,
both in the entire genome and in exons only (Figure 2,
Additional file 1: Table S1). Furthermore, the lengths of
indels in STRs are in agreement with the STR period (Fig-
ure 3, Additional file 1: Table S2), indicating that indels
may be generated by slipped-strand mispairing [16].
The majority of indels found in exons have lengths differ-
ent from the codon size (3, 6 or 9 bp), both inside and
outside STRs (Figure 4). To test whether the increased fre-
quency of indels is confined to long tandem repeat-like
regions, we limited our analysis to STRs (≤25 bp) not
overlapping with known tandem repeats. We found that
the higher frequency of indels in STRs is preserved (Addi-
tional file 1: Figure S1) in the set of STRs with length ≤25
bp.
STRs are overrepresented in disease genes
First, we found that exons of disease-related genes gener-
ally are longer than those of reference genes, and also that
the amount of STRs in exons is larger in disease genes than
in reference genes (Figure 5 and Additional file 1: Figure
S2). To compare the amount of STRs in different subsets
of genes we therefore used the relative amount of STRs in
a gene, i.e. the length of STRs in the gene relative to the
length of the gene. We found that all four subsets of dis-
ease-related genes had significantly higher relative
amounts of STR regions in exons than non-disease-related
genes, and that almost all disease-related genes have STRs
in their exons (Table 1, Additional file 1: Figure S2). In
contrast, this is not true if we consider introns instead of
exons (Additional file 1: Table S4). To validate the find-
ings, we replicated the analysis in mouse using data from
the Mouse Genome Database (MGD) [17] and obtained
similar results (Table 1, Additional file 1: Figures S2).
Unsurprisingly, we found more STRs of periods 3, 6, 9 in
exons than in the entire genome (Figure 6A, C), but there
appears to be no obvious correlation between disease sta-
tus and STR period (Figure 6B, D). Furthermore, the
observed excess of STRs in disease genes is preserved when
using only STRs of periods different from 3, 6 or 9 bp
(Additional file 1: Table S3)
Our definition of STR focuses specifically on small, peri-
odic regions with few repeats. To see if the pattern mainly
originates from known tandem repeats, we excluded both
long STRs (>25 bp) as well as all STRs overlapping the
UCSC simple repeats track (see Methods) and found that
the results were not affected (Additional file 1: Table S5).
We also allow for imperfections in the definition of STR
(see Methods) which potentially biases our results: If
more polymorphic sites are known in disease-related
genes than in other genes, then this could lead to an (arti-
ficial) excess of STRs in disease-related genes. To test
whether this is the case, we defined STR from the reference
sequence alone (ignoring known polymorphic sites),
redid the analysis and found that the results were not
affected (Additional file 1: Table S6).
Discussion
Our definition of STR identify short, possibly imperfect
tandem repeats as short as 9 bp with the motif repeated at
least 3 times; it takes both known genetic variation and
rare pattern deviations into account. As there is no con-
sensus in the literature about cut-off values for identifica-
tion of STRs [20], we chose cut-off values of 3 repeats and
9 bp minimum length. Interestingly, two other studies
point to these cut-off values as reasonable: Ref [21] iden-
tifies orthologous, alignable STRs in the human and chim-
panzee reference genomes and estimate that polymerase
slippage is negligible below 10 bp. Ref [22] compiles a
microsatellite data set with perfect repeats from the refer-
ence genome and estimates that polymerase slippage
mutations do rarely occur unless the STR length is >8–9
bp and the number of repeats >3. Both studies use only
the reference genome(s) and mathematical models to esti-
mate the slippage threshold.
Distribution of indels inside versus outside STRs Figure 2
Distribution of indels inside versus outside STRs. Both 
insertions and deletions are more frequent inside (red bars) 
than outside (black bars) STRs (P-values shown above col-
umns), in the entire genome as well as in exons only.
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We have used a specialized algorithm to detect STRs, but
other tandem repeats detecting software could potentially
identify similar sequences, if the parameters of the soft-
ware are tuned to look for shorter tandem repeats than
those found using the default/standard parameters. How-
ever the existing software for tandem repeat detection dif-
fer significantly in what is identified as STRs (using
default/standard settings) and hence the resulting STR
content depends on the software [22]. One benefit of our
definition is that it is straightforward to verify whether a
sequence is STR.
Indels involved in diseases are well known [15,18,19]
which suggests that the observed excess of STRs in the
exons of disease-related genes is linked to the excess of
indels in STRs. As described earlier, long tandem repeats
in human exons contain almost no repeats with periods
different from 3, 6 or 9 bp [8,9], and most diseases related
to known tandem repeats are caused by expansion of 3-
repeat elements (Trinucleotide Disease). This is in marked
contrast to our findings showing that more than 50% of
exonic STRs have periods different from 3, 6 and 9 bp and
that the observed excess of STRs in disease-related genes is
preserved when using only STRs with periods different
from 3, 6 and 9 bp. The basic explanation is that STRs gen-
erally are shorter and/or less perfect than tandem repeats,
and not detected by the commonly used tandem repeats
software.
The main difference between the reference genes and the
four sets of disease-related genes is a difference in number
of zero- or low STR content (Figure 5). The reference set
contains 10–12 % genes with no STRs at all, whereas this
fraction is substantially lower in the four disease-related
sets. A possible explanation could be failure to detect STRs
in really short genes, but when we removed short genes
(<1000 bases) from the analysis, the results were not
affected (data not shown). We conclude that the most
likely explanation is a link between STR content, hyper-
mutability and disease-status.
The observed association with disease genes, hypermuta-
bility and wide distribution of STRs suggests that STRs in
exons may be good candidates to screen for rare disease
causing mutations. This is supported by the observation
that exons of disease related genes virtually always har-
bour STRs (Figure 5). Today, primarily genome-wide SNP
association studies are used to identify genetic variants or
regions implicated in disease, but next-generation
sequencing technologies possibly will enable comprehen-
sive whole-genome sequencing of individuals. However,
sequencing the entire genome of a large group of affected
individuals may still be prohibitively expensive for years
to come, and alternative strategies are welcomed. Since
there are only 1,973,844 bp of STR segments in human
exons and 99% of them are shorter than 33 bp, it may be
feasible to screen for rare mutations using selective rese-
Indel length versus STR period Figure 3
Indel length versus STR period. Left: correlation between STR period and insertion lengths. Circle area is proportional to 
the number of observations. Right: correlation between STR period and deletion length. 25 indels longer than 9 bp are omit-
ted. See Additional file 1: Table S2 for counts.
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quencing of STR regions at a reasonable price and effort
[23].
Conclusion
In summary, 92% of all human genes have STRs in their
exons according to the definition used in this paper.
Despite their short lengths and simple definition STRs
capture a large amount of the known exonic indels and
are significantly overrepresented in disease-related genes.
These findings constitute STRs as an obvious target when
screening for rare disease causing mutations, because of
the relatively low amount of STRs in exons (1,973,844 bp
in human; 1,544,242 bp in mouse) and the limited length
of STR regions (99% are shorter than 33 bp).
Materials and methods
Reference genome sequences
The human reference genome [24] (hg18, NCBI build 36)
and the mouse reference genome [25] (mm8, NCBI 36)
were used in the analyses. Base pairs assigned 'N' (i.e.
gaps) in the reference sequences were omitted in the anal-
ysis and the pruned genomes were referred to as the
"entire genomes" (human genome length: 2,858,013,089
bp; mouse genome length: 2,550,169,439 bp).
Short tandem repeat identification
We identified STRs by scanning the genomes for DNA seg-
ments that fulfil four criteria. A sequence is defined as STR
with period p, if it fulfils the following: (1) the length of
the sequence is at least 9 bp, (2) a motif (e.g., AT in
ATATATATAT) of length p(≥1) is repeated at least three
times with (3) at most one bp not matching a perfect rep-
etition of the motif in sliding windows of max(12, 3·p)
bp, and (4) the two flanking bp of the sequence must
match the motif. Known polymorphic single nuclear sub-
stitutions are used to allow mismatches in the reference
genome, consequently all possible alleles are analyzed
(Figure 1). We used all polymorphic single nuclear substi-
tutions from ENSEMBL 46 (containing dbSNP build 127
[26] for humans and dbSNP build 126 for mouse [26]).
The data were downloaded as the "ENSEMBL 46 VARIA-
TION" track from the BioMart Browser [27]. If a STR
sequence is assigned more than one period, we used the
smallest.
Only 0.8% of all STRs with periods 1–25 have period > 9
(Additional file 1: Figure S3), hence we only used periods
<10 bp when analyzing the entire genomes. The entire
human genome has 114,996,351 bp tagged as STRs
(4.02% of the entire genome), and the entire mouse
genome contains 137,927,765 bp tagged as STRs (5.41%
of the entire genome).
Indels
We used all insertions and deletions (indels) from
ENSEMBL 46 (containing dbSNP build 127 [26]). The
Distribution of indel lengths in exons Figure 4
Distribution of indel lengths in exons. Left: insertions of different lengths inside STRs (red bars) and outside STRs (black 
bars). Right: deletions of different lengths inside and outside STRs. A majority of all insertions have a length different from 3, 6 
or 9 bp; both inside and outside STRs.
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data were downloaded as the "ENSEMBL 46 VARIATION"
track from the BioMart Browser [27]. To obtain validated
indels only, the data were filtered to contain only observa-
tions with validation "freq" and/or "doublehit" (the
minor allele is seen at least twice) and Mapweight 1 (the
highest quality alignments), resulting in 4,351 validated
insertions and 16,899 validated deletions. To differentiate
between insertions and deletions, we used the state given
by dbSNP, which is defined according to the reference
sequence.
Disease-related gene sets
Human and mouse genes were downloaded using
BioMart (ENSEMBL 46) [27] only including "KNOWN"
genes with "KNOWN" transcripts. This resulted in 21,658
human genes with 39,684 transcripts and 21,946 mouse
genes with 28,576 transcripts. If a gene had multiple tran-
scripts we clustered all exons from all transcripts into one
super-transcript.
The OMIM Morbid Map (August 30, 2007) which con-
tains the cytogenetic map locations of all disease genes
described in the OMIM database [28] was used to assign
disease status of human genes. We created four sets of
human disease genes: The general set (all diseases, 2095
genes) consists of all Morbid Map genes, except genes
annotated with terms related to homosexuality and pro-
tections against diseases. Three subsets were defined using
disease terms: A leukaemia set (70 genes, term: 'leukae-
mia'), a cancer set excluding leukaemia (151 genes, terms:
'carcinom', 'cancer', 'tumour', 'burkitt lymphoma', 'malig-
nant melanoma', 'multiple endocrine neoplasia', 'neurofi-
bromatosis', 'polycystic kidney disease', 'harvey ras
oncogene', 'retinoblastoma', 'tuberous sclerosis' and 'von
hippel-lindau syndrome') and an immune system disease
set, excluding cancer and leukaemia (52 genes, terms:
'asthma', 'ataxia telangiectasia', 'autoimmune', 'digeorge
syndrome' and 'immunodeficiency').
We defined two non-overlapping sets of mouse disease
genes. The first set of 294 mouse cancer genes is the result
of querying the Mouse Genome Database (MGD) [29] for
"increased tumour incidence" in the mammalian pheno-
type ontology [29]. The second set consists of 764 mouse
Table 1: Estimated STR overrepresentation in disease-related genes, relative to the proportion of STR in reference genes.
Gene set #Genes STR overrepresentation a P-value
Human genes
Reference set 11210 - -
All diseases 2095 7.0 % [4.6, inf] 2.1 × 10-7
Leukaemia 70 28.3 % [15.2, inf] 1.7 × 10-4
Cancers 151 17.5 % [8.8, inf] 3.3 × 10-4
Immune system diseases 52 16.5 % [3.0, inf] 2.1 × 10-2
Mouse genes
Reference set 17077 - -
Cancers 294 12.1 % [5.3, inf] 7.6 × 10-4
Postnatal lethality 764 25.7 % [21.6, inf] <10-12
a 95% confidence intervals are in brackets.
STR content in the exons of human disease genes Figure 5
STR content in the exons of human disease genes. 
Absolute STR amount for human reference genes and the 
four sets of disease genes with number of genes shown in 
parentheses. Genes are ranked by absolute STR content, 
with the STR poorest genes to the left. Note the virtually all 
disease genes harbour STRs in their exons.
0.0 0.2 0.4 0.6 0.8 1.0
0
1
0
0
2
0
0
3
0
0
4
0
0
5
0
0
Genes ranked by absolute STR content
S
T
R
 
c
o
n
t
e
n
t
 
(
b
p
)
Absolute STR content
(Total STR length < 500 bp only)
Reference set (n=11210)
All diseases (n=2093)
Leukaemia (n=70)
Cancer (n=151)
Immune system diseases (n=52)BMC Genomics 2008, 9:410 http://www.biomedcentral.com/1471-2164/9/410
Page 7 of 9
(page number not for citation purposes)
genes associated with "postnatal lethality" after removal
of genes overlapping the cancer set.
Reference gene sets
The reference set of "non-disease-related" human genes
was defined as the 11,210 known genes not found in the
OMIM database, whereas the mouse reference set was
defined as the 17,171 known mouse genes not mapped to
the mammalian phenotype ontology [29].
Known tandem repeats
The "Simple Repeats" track in the UCSC Genome Browser
[30] act as a de facto definition of tandem repeats (possibly
imperfect), identified by Tandem Repeats Finder [31]. The
track was created using the following parameter settings
for TRF; match = 2, mismatch = 7, indels = 7, matching
probability = 0.80, indel probability = 0.10, maximum
period = 50, and minimum alignment score = 2000.
Distribution of STR periods Figure 6
Distribution of STR periods. The proportion of STR of each period in the human (A) and mouse (C) genome; a segment of 
STR is always assigned to the lowest possible period. The proportion of STR of each period, for each of the disease sets in 
human (B) and mouse (D).
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B: Distribution of STR periods in disease sets
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STRs outside known tandem repeats
STRs outside known tandem repeats are defined by apply-
ing the following two filters: (A) STRs inside known tan-
dem repeats are omitted from the analysis; (B) all
contiguous segments of STRs are clustered, and all such
clusters which are more than 25 bp long are omitted from
the analysis.
Statistical methods
To test for excess of insertions/deletions in STRs, we used
a binomial test. The observed number of insertions/dele-
tions inside STRs was compared to the binomial distribu-
tion b(n, p) where n  is the total number of validated
insertions/deletions and p = 0.0402 is the proportion of
STRs in the human genome. We define an indel to be
inside a STR segment if the midpoint of the indel is within
the segment. The midpoint is defined as (s+e)/2, where s
is the start coordinate and e is the end coordinate of the
indel.
The distribution is relative STR amount is non-Gaussian
(Additional file 1: Figure S4) and a standard t-test cannot
be applied. Instead, we used the Wilcoxon rank-sum test
[32] to compare the relative STR amount in disease-
related genes to the relative amount in reference genes,
because the test does not require assumptions about the
underlying distribution of relative STR amount. The STR
overrepresentation for each disease-related gene set is
found by comparing the estimated median relative STR
content in the disease-related gene set to the estimated
median relative STR content in the reference gene set.
Confidence intervals of the estimated overrepresentation
are obtained by Gaussian approximation of the distribu-
tion of rank sums from the Wilcoxon rank-sum test.
All data were analyzed using Python http://
www.python.org and R http://www.R-project.org[33]. All
scripts are available upon request.
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